Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antitumor Activity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06756932
What this trial is testing

BGB-21447 (Bcl-2 Inhibitor) Combinations for Adults With Hormone-Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Metastatic Breast Cancer

Who this might be right for
Hormone-receptor-positive Breast CancerHER2-negative Breast CancerMetastatic Breast Cancer
BeOne Medicines 120
Early research (Phase 1)Study completedNCT06001671
What this trial is testing

Antitumor Activity and Safety of BEBT-109, a Novel EGFR Inhibitor, in Previously Treated NSCLC

Who this might be right for
NSCLC
Hunan Province Tumor Hospital 23
Early research (Phase 1)Not Yet RecruitingNCT07391644
What this trial is testing

JSKN027 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Malignant Solid Tumor
Jiangsu Alphamab Biopharmaceuticals Co., Ltd 250
Testing effectiveness (Phase 2)Looking for participantsNCT06554795
What this trial is testing

First-in-human Study of DB-1419 for Advanced/Metastatic Solid Tumors

Who this might be right for
Solid Tumor, Adult
DualityBio Inc. 360
Early research (Phase 1)Study completedNCT03106428
What this trial is testing

A Multiple Ascending Dose Study of MEDI7247 in Patients With Selected Relapsed/Refractory Hematological Malignancies

Who this might be right for
Acute Myeloid LeukemiaMultiple MyelomaDiffuse Large B-cell Lymphoma
MedImmune LLC 67
Testing effectiveness (Phase 2)Active Not RecruitingNCT05262400
What this trial is testing

Learn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants With Breast Cancer and Solid Tumors

Who this might be right for
Breast CancerSolid Tumors
Pfizer 235
Early research (Phase 1)Ended earlyNCT06573294
What this trial is testing

Trial to Assess the Safety and Antitumor Activity of GEN1057 in Malignant Solid Tumors

Who this might be right for
Advanced Malignant Solid TumorsMetastatic Malignant Solid Tumors
Genmab 23
Early research (Phase 1)Looking for participantsNCT07292402
What this trial is testing

JSKN022 in Subjects With Advanced Malignant Solid Tumors

Who this might be right for
Advanced Malignant Solid Tumors
Jiangsu Alphamab Biopharmaceuticals Co., Ltd 225
Testing effectiveness (Phase 2)Study completedNCT05830539
What this trial is testing

IN10018 Combination Therapy in Previously-treated Locally Advanced or Metastatic Solid Tumor Patients

Who this might be right for
Locally Advanced or Metastatic Solid Tumors
InxMed (Shanghai) Co., Ltd. 68
Testing effectiveness (Phase 2)Ended earlyNCT05491317
What this trial is testing

A Safety and Antitumor Activity Trial of Immunoradiotherapy Combinations as a Treatment Option for Subjects With Metastatic Solid Tumors

Who this might be right for
Non-CNS Tumor
Genmab 13
Early research (Phase 1)Study completedNCT03490669
What this trial is testing

Study to Evaluate Safety, PK, PD, Immunogenicity & Antitumor Activity of MSC-1 in Patients With Adv Solid Tumors

Who this might be right for
Advanced Solid TumorsPancreatic CancerNon Small Cell Lung Cancer+1 more
AstraZeneca 41
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07282873
What this trial is testing

Study of TYK-01054 Capsules in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor MalignanciesMalignant Mesothelioma (MM)
TYK Medicines, Inc 219
Early research (Phase 1)Study completedNCT02705482
What this trial is testing

Evaluate MEDI0562 in Combination With Immune Therapeutic Agents in Adult Subjects With Advanced Solid Tumors

Who this might be right for
Select Advanced Solid Tumors
MedImmune LLC 58
Early research (Phase 1)Ended earlyNCT02187848
What this trial is testing

Evaluation of SAR408701 in Patients With Advanced Solid Tumors

Who this might be right for
Neoplasm Malignant
Sanofi 254
Early research (Phase 1)Study completedNCT03724747
What this trial is testing

Study to Evaluate the Safety, Tolerability,Pharmacokinetics, and Antitumor Activity of a Thorium-227 Labeled Antibody-chelator Conjugate Alone and in Combination With Darolutamide, in Patients With Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Metastatic Castration Resistant Prostate Cancer (mCRPC)
Bayer 63
Testing effectiveness (Phase 2)Looking for participantsNCT06234098
What this trial is testing

Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmocodynamics and Preliminary Antitumor Activity of AT-1965 in Patients With Advanced, Refractory or Recurrent Solid Tumors

Who this might be right for
Solid Tumor
Alyssum Therapeutics 100
Early research (Phase 1)Study completedNCT02432235
What this trial is testing

Study of ADCT-301 in Patients With Relapsed or Refractory Hodgkin and Non-Hodgkin Lymphoma

Who this might be right for
Hodgkin LymphomaNon-Hodgkin Lymphoma
ADC Therapeutics S.A. 133
Testing effectiveness (Phase 2)Active Not RecruitingNCT04666740
What this trial is testing

Pembrolizumab and Olaparib for People With Metastatic Pancreatic Ductal Adenocarcinoma and Homologous Recombination Deficiency or Exceptional Treatment Response to Platinum-Based Therapy

Who this might be right for
Metastatic Pancreatic Ductal AdenocarcinomaHomologous Recombination Deficiency (HRD)
Memorial Sloan Kettering Cancer Center 63
Early research (Phase 1)Study completedNCT05822843
What this trial is testing

ESG206 in Adult Subjects With B-cell Lymphoid Malignancies

Who this might be right for
B-cell Lymphoid Malignancies
Shanghai Escugen Biotechnology Co., Ltd 13
Testing effectiveness (Phase 2)Study completedNCT03565003
What this trial is testing

A First-in-Human Study of JAB-3068 (SHP2 Inhibitor) in Adult Patients With Advanced Solid Tumors in China

Who this might be right for
Non-small Cell Lung CancerHead and Neck CancerEsophageal Cancer+1 more
Jacobio Pharmaceuticals Co., Ltd. 126
Next Page